Efficacy of lifestyle intervention in adults with impaired glucose tolerance with and without impaired fasting plasma glucose: a post hoc analysis of Da Qing Diabetes Prevention Outcome Study
Supporting Files
-
10 2021 ; 10-2021
-
Available in CDC Stacks on 2022-10-01T00:00:00Z
File Language:
English
Details
-
Alternative Title:Diabetes Obes Metab
-
Personal Author:
-
Corporate Authors:
-
Description:Aims ; The extent that pre-diabetic fasting plasma glucose (FPG) levels influence the effectiveness of lifestyle interventions in preventing type 2 diabetes (T2DM) is uncertain. We aimed to determine if the outcome of lifestyle intervention in people with impaired glucose tolerance (IGT) differs in those with normal or impaired FPG levels. ; Methods ; Using data from the Da Qing Diabetes Prevention Outcome Study, a 30-year follow-up of a six-year randomized trial of lifestyle intervention in 576 people with IGT, we conducted a post-hoc analysis to compare the efficacy of intervention to reduce the incidence of T2DM and its complications in those with baseline FPG <100mg/dL and FPG ≥100 mg/dL. ; Results ; Lifestyle intervention reduced the cumulative incidence of T2DM by 37–46% in those with baseline FPG <100mg/dL and by 47–51% in those with FPG ≥100 mg/dL. The FPG <100 mg/dL group had a lower cumulative incidence of diabetes and 6.41years median delay in its onset compared with 2.21 years delay in the FPG >100 mg/dL group. In those with FPG <100 mg/dL intervention was associated with at least as great a reduction in cardiovascular disease (CVD) and all-cause mortality as in the FPG >100 mg/dL group. ; Conclusions ; Lifestyle intervention reduced the incidence of T2DM in people with IGT regardless of baseline FPG levels, and in those with FPG <100 mg/dL led to a substantial delay in its onset. All persons with IGT, with normal or impaired FPG levels, may benefit from lifestyle intervention to delay its onset and mitigate the incidence of T2DM.
-
Subjects:
-
Keywords:
-
Source:Diabetes Obes Metab. 23(10):2385-2394
-
Pubmed ID:34212465
-
Pubmed Central ID:PMC8429240
-
Document Type:
-
Funding:
-
Volume:23
-
Issue:10
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha-512:40bdc2db72ee7b3924191cd748b6ad976afe0e54adb0af9a6ff7f80aa3148dc04c474f87c197835d435410223df1c7ba74ce7e656264dbb8b063fba9150d75e4
Supporting Files
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access